Compare GEVO & DSU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GEVO | DSU |
|---|---|---|
| Founded | 2005 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Finance Companies |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 470.1M | 548.1M |
| IPO Year | 2011 | N/A |
| Metric | GEVO | DSU |
|---|---|---|
| Price | $2.07 | $10.29 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $6.42 | N/A |
| AVG Volume (30 Days) | ★ 2.7M | 148.2K |
| Earning Date | 03-05-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 10.06% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $120,932,000.00 | N/A |
| Revenue This Year | $913.54 | N/A |
| Revenue Next Year | $11.79 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 675.75 | N/A |
| 52 Week Low | $0.92 | $9.22 |
| 52 Week High | $2.95 | $11.40 |
| Indicator | GEVO | DSU |
|---|---|---|
| Relative Strength Index (RSI) | 47.46 | 52.95 |
| Support Level | $1.94 | $10.16 |
| Resistance Level | $2.08 | $10.40 |
| Average True Range (ATR) | 0.09 | 0.08 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 46.94 | 52.08 |
Gevo Inc is a renewable chemicals and biofuels company engaged in the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. The operating segments are the Gevo segment, GevoFuels segment, and the GevoRNG segment. By its segments, it is involved in research and development activities related to the future production of SAF, commercial opportunities for other renewable hydrocarbon products and isobutanol, including the development of its biocatalysts, and the produces-pipeline quality methane gas captured from dairy cow manure. The company derives maximum revenue from the GevoRNG segment.
Blackrock Debt Strategies Fund Inc is a diversified, closed-end management investment company. Its investment objective is to provide current income by investing in a diversified portfolio of U.S. companies' debt instruments including corporate loans. The fund's secondary investment objective is to provide capital appreciation.